PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2015

Protective Effect of Infliximab Against Carbon Tetrachloride-Induced Hepatotoxicity.

Rat / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 26081035 ↗2015Reported benefit

Protective Effect of Infliximab Against Carbon Tetrachloride-Induced Hepatotoxicity.

RatChemical/toxinSprague-DawleyMalen = 24 rats in three groups of 87 mg/kg24 h before carbon tetrachloride administration

Model: Acute liver injury induced by a single 2 mL/kg dose of carbon tetrachloride

Carbon tetrachloride raised aminotransferases, transforming growth factor beta 1, interleukin 1 beta and adenosine deaminase and lowered carbamoyl phosphate synthetase I and carbonic anhydrase II. Pretreatment with infliximab reversed these changes and reduced histological liver injury.

Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.